Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Cancer Research and Clinical Oncology
|
April 25, 2018
Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
M Faehling, J Achenbach, P Staib, et al.
Diabetes
|
January 8, 1998
Electrophysiological and metabolic characterization of single beta-cells and islets from diabetic GK rats
S J Hughes, M Faehling, C W Thorneley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2021
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
S Peters, J-L Pujol, U Dafni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencing
P Christopoulos, M Kirchner, J Roeper, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Cancer Research and Clinical Oncology
|
April 25, 2018
Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
M Faehling, J Achenbach, P Staib, et al.
Diabetes
|
January 8, 1998
Electrophysiological and metabolic characterization of single beta-cells and islets from diabetic GK rats
S J Hughes, M Faehling, C W Thorneley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 25, 2021
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
S Peters, J-L Pujol, U Dafni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencing
P Christopoulos, M Kirchner, J Roeper, et al.
Page
of 2